477 related articles for article (PubMed ID: 19414421)
1. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
[TBL] [Abstract][Full Text] [Related]
2. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
[TBL] [Abstract][Full Text] [Related]
3. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
Ozols RF
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
[TBL] [Abstract][Full Text] [Related]
4. [Intraperitoneal chemotherapy for ovarian cancer].
Noma J; Yoshida N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD
Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
[No Abstract] [Full Text] [Related]
7. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.
Muggia FM
Semin Oncol; 2006 Dec; 33(6 Suppl 12):S18-24. PubMed ID: 17223446
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal chemotherapy in ovarian cancer remains experimental.
Gore M; du Bois A; Vergote I
J Clin Oncol; 2006 Oct; 24(28):4528-30. PubMed ID: 17008689
[No Abstract] [Full Text] [Related]
9. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
Marin K; Oleszewski K; Muehlbauer P
Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view.
Vergote I; Amant F; Leunen K; Cadron I; Van Gorp T; Neven P; Berteloot P
Oncologist; 2008 Apr; 13(4):410-4. PubMed ID: 18448555
[TBL] [Abstract][Full Text] [Related]
12. ACOG Committee Opinion No. 396. Intraperitoneal chemotherapy for ovarian cancer.
American College of Obstetricians and Gynecologists
Obstet Gynecol; 2008 Jan; 111(1):249. PubMed ID: 18165421
[TBL] [Abstract][Full Text] [Related]
13. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Naumann RW; Sukumvanich P; Edwards RP
Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
[TBL] [Abstract][Full Text] [Related]
14. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside.
de Bree E; Theodoropoulos PA; Rosing H; Michalakis J; Romanos J; Beijnen JH; Tsiftsis DD
Cancer Treat Rev; 2006 Oct; 32(6):471-82. PubMed ID: 16942841
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
Fung-Kee-Fung M; Provencher D; Rosen B; Hoskins P; Rambout L; Oliver T; Gotlieb W; Covens A;
Gynecol Oncol; 2007 Jun; 105(3):747-56. PubMed ID: 17368522
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy supporting the role of intraperitoneal drug delivery in the primary chemotherapeutic management of small-volume residual advanced ovarian cancer.
Markman M
Semin Oncol; 2006 Dec; 33(6 Suppl 12):S3-7. PubMed ID: 17223444
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
Almadrones L
Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
Potter KL; Held-Warmkessel J
Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
[TBL] [Abstract][Full Text] [Related]
20. [Second line chemotherapy of carcinoma of the ovary. Current approaches].
Sesti F; Mantenuto L; Ciancaglini G; Zupi E; Terenzi S; Piccione E
G Ital Oncol; 1989; 9(4):121-4. PubMed ID: 2693348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
